World's Best Scientists 2026 revealed!
Peter E. Schwartz

Peter E. Schwartz

D-Index & Metrics

Medicine

D-Index
87
Citations
26043
World Ranking
13713
National Ranking
6963

Peter E. Schwartz publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Peter E. Schwartz sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 541 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Peter E. Schwartz D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Peter E. Schwartz sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 87 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Peter E. Schwartz is affiliated with Yale University in the United States. Their research is primarily situated in the field of Medicine, with a significant focus on Oncology and related subfields such as Reproductive Medicine, Pulmonary and Respiratory Medicine, Molecular Biology, and Cancer Research.

The scientist's research topics cover a range of subjects concentrated on cancer diagnosis and treatment, including:

  • Ovarian cancer diagnosis and treatment
  • HER2/EGFR in Cancer Research
  • Monoclonal and Polyclonal Antibodies Research
  • Sarcoma Diagnosis and Treatment
  • PARP inhibition in cancer therapy
  • Intraperitoneal and Appendiceal Malignancies
  • Cell Adhesion Molecules Research

Recent papers authored or co-authored by Peter E. Schwartz include:

  • Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis, 2020, Clinical Cancer Research
  • Integrated mutational landscape analysis of uterine leiomyosarcomas, 2021, Proceedings of the National Academy of Sciences
  • A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability, 2021, Cancer
  • Cervical carcinomas that overexpress human trophoblast cell-surface marker (Trop-2) are highly sensitive to the antibody-drug conjugate sacituzumab govitecan, 2020, Scientific Reports
  • Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38), in Ovarian Cancer, 2020, Frontiers in Oncology

Frequent co-authors collaborating with Peter E. Schwartz include:

  • Elena Ratner
  • Alessandro D. Santin
  • Masoud Azodi
  • Gary Altwerger
  • Stefania Bellone

The scientist's work appears in a variety of publication venues, with multiple publications in:

  • Gynecologic Oncology
  • Clinical Cancer Research
  • Proceedings of the National Academy of Sciences
  • Journal of Clinical Oncology
  • British Journal of Cancer

Best Publications

  • Serum protein markers for early detection of ovarian cancer

    Gil Mor;Irene Visintin;Yinglei Lai;Hongyu Zhao

  • Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance.

    Ayesha B. Alvero;Rui Chen;Han-Hsuan Fu;Michele Montagna

  • Diagnostic Markers for Early Detection of Ovarian Cancer

    Irene Visintin;Ziding Feng;Gary Longton;David C. Ward

  • High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients.

    Urania Magriples;Frederick Naftolin;Peter E. Schwartz;Maria Luisa Carcangiu

  • Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu

    Amanda N. Fader;Dana M. Roque;Eric Siegel;Natalia Buza

  • BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer

    Roxana Moslehi;Roxana Moslehi;William Chu;Beth Karlan;David Fishman

  • Psychosocial benefits of a cancer support group.

    Eileen N. Cain;Ernest I. Kohorn;Donald M. Quinlan;Kate Latimer

  • Regulation of IKKβ by miR-199a affects NF-κB activity in ovarian cancer cells

    R Chen;A B Alvero;D A Silasi;M G Kelly

  • A CASE-CONTROL STUDY OF CANCER OF THE ENDOMETRIUM

    Jennwer L. Kelsey;Virginia A. Livolsi;Theodore R Holford;Diana B. Fischer

  • Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma.

    B E Nelson;A T Rosenfield;P E Schwartz

  • AN EPIDEMIOLOGIC STUDY OF EPITHELIAL CARCINOMA OF THE OVARY

    Nancy G. Hildreth;Jennifer L. Kelsey;Virginia A. Livolsi;Diana B. Fischer

  • Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma.

    Siming Zhao;Murim Choi;John D. Overton;Stefania Bellone

  • Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci

    Mary Carrington;Sophia Wang;Maureen P. Martin;Xiaojiang Gao

  • Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary.

    Jacob Tangir;Daniel Zelterman;Wenging Ma;Peter E Schwartz

  • Low-grade endometrial stromal sarcoma: hormonal aspects☆

    Micheline C Chu;Gil Mor;Chungyun Lim;Wenxin Zheng

  • Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

    Antonis C. Antoniou;Jonathan Beesley;Lesley McGuffog;Olga M. Sinilnikova

  • Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease.

    June Y. Hou;Michael G. Kelly;Herbert Yu;Jessica N. McAlpine

  • Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis.

    Amanda N. Fader;Dana M. Roque;Eric Siegel;Natalia Buza

  • The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.

    Wenxin Zheng;Xiaofang Yi;Oluwole Fadare;Oluwole Fadare;Sharon X. Liang

  • Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy

    Michael G. Kelly;David M. O'malley;Pei Hui;Jessica Mcalpine

Frequent Co-Authors

Alessandro D. Santin
Alessandro D. Santin Yale University
Sergio Pecorelli
Sergio Pecorelli University of Brescia
Gil Mor
Gil Mor Wayne State University
Lingeng Lu
Lingeng Lu Yale University
Neil J. MacLusky
Neil J. MacLusky University of Guelph
Cary P. Gross
Cary P. Gross Yale University
Melinda L. Irwin
Melinda L. Irwin Yale University
Harvey A. Risch
Harvey A. Risch Yale University
Jason D. Wright
Jason D. Wright Columbia University
Virginia A. LiVolsi
Virginia A. LiVolsi University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare can open up rewarding career opportunities for those interested in medicine, but looking for flexible or accessible online routes. For students who want to enter the field quickly, there are easy nursing programs to get into that offer a streamlined admission process, helping aspiring nurses start their education without lengthy waiting periods.

Some students may be concerned about standardized testing. Fortunately, there are nursing school that don't require teas or other entrance exams, making the application process more accessible.

If you’re interested in administration or working behind the scenes, earning a health administration degree online may be the right choice. These programs prepare students for management roles in hospitals, clinics, and other healthcare settings.

For those drawn to healthcare but not direct patient care, consider exploring medical billing and coding schools online. This field is vital for the smooth operation of healthcare facilities and offers strong career prospects—all from a remote or flexible learning environment.

Best Scientists Citing Peter E. Schwartz

Trending Scientists

Recently Published Articles